Journal of Family Medicine and Primary Care

REVIEW ARTICLE
Year
: 2019  |  Volume : 8  |  Issue : 7  |  Page : 2184--2188

Fimasartan: A new armament to fight hypertension


Akshyaya Pradhan, Vikas Gupta, Rishi Sethi 
 Department of Cardiology, King George Medical University, Lucknow, Uttar Pradesh, India

Correspondence Address:
Dr. Akshyaya Pradhan
Department of Cardiology, King George's Medical University, Lucknow - 226 003, Uttar Pradesh
India

Hypertension is a major public health problem of modern era. Fimasartan is a new Angiotensin Receptor Blocker approved for treatment of hypertension. It is more potent and longer acting angiotensin receptor blocker with effects lasting over 24 hours. Many clinical studies have affirmed its role in pharmacotherapy of hypertension. Further, it is renoprotective and has proven beneficial in diabetes also. This article briefly discusses the pharmacology and clinical evidence with fimasartan with a short summary of previous angiotensin receptor blockers.


How to cite this article:
Pradhan A, Gupta V, Sethi R. Fimasartan: A new armament to fight hypertension.J Family Med Prim Care 2019;8:2184-2188


How to cite this URL:
Pradhan A, Gupta V, Sethi R. Fimasartan: A new armament to fight hypertension. J Family Med Prim Care [serial online] 2019 [cited 2019 Aug 24 ];8:2184-2188
Available from: http://www.jfmpc.com/article.asp?issn=2249-4863;year=2019;volume=8;issue=7;spage=2184;epage=2188;aulast=Pradhan;type=0